Menu
Back to Journals » Journal of Blood Medicine » Volume 13
Use of Plerixafor for Stem Cell Mobilization in the Setting of Autologous and Allogeneic Stem Cell Transplantations: An Update [Corrigendum]
Authors Bilgin YM
Received 30 August 2022
Accepted for publication 30 August 2022
Published 5 September 2022 Volume 2022:13 Pages 483—484
Bilgin YM. J Blood Med. 2021;12:403–412.
The author wishes to advise of an error in the units of measurement for CD34 concentrations which were shown as 109/L but should have been 106/L throughout the paper.
The author apologizes for any inconvenience and advises it does not affect the results of the paper.
© 2022 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.